MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$1,131,800K
(44.84%↑ Y/Y)
Loss before income
taxes
-$1,107,700K
(48.03%↑ Y/Y)
Provision for (benefit
from) income taxes
$24,100K
(130.31%↑ Y/Y)
Labs
$1,505,700K
Point Of Care
$601,600K
Immunohematology
$543,800K
Donor Screening
$52,600K
Molecular Diagnostics
$26,500K
Operating (loss) income
-$919,200K
(53.12%↑ Y/Y)
Interest expense, net
$177,600K
(8.62%↑ Y/Y)
Other expense, net
-$5,800K
(18.31%↑ Y/Y)
Loss on
extinguishment of debt
-$5,100K
Total revenues
$2,730,200K
(-1.89%↓ Y/Y)
Cost of sales,
excluding amortization of...
$1,456,000K
(-2.70%↓ Y/Y)
Selling, marketing and
administrative
$746,300K
(-2.67%↓ Y/Y)
Goodwill impairment
charge
$700,700K
(-61.55%↓ Y/Y)
Restructuring, integration and
other charges
$263,600K
Amortization of intangible
assets
$189,200K
(-6.98%↓ Y/Y)
Research and development
$186,200K
(-14.86%↓ Y/Y)
Other operating
expenses
$97,700K
(88.61%↑ Y/Y)
Asset impairment
charge
$9,700K
(-82.95%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)